Market
Dexcom lifts 2026 revenue outlook after positive Q3
Dexcom raised its 2026 revenue guidance to $5.2–$5.25 billion, up from a prior low-end forecast of $5.18 billion, following stronger-than-expected third-quarter results. The continuous glucose monitoring company's upward revision reflects sustained demand for its core glucose-sensing platform.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network